Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I/II trial

被引：0
|
作者：
Yamanaka, R [1 ]
Homma, J [1 ]
Yajima, N [1 ]
Tsuchiya, N [1 ]
Tanaka, R [1 ]
机构：
[1] Niigata Univ, Brain Res Inst, Niigata, Japan
来源：
MOLECULAR THERAPY | 2004年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
254
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [21] Superior anti-tumour immune response of dendritic cells fused with prostate cancer cells compared with tumour lysate-pulsed dendritic cells
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 161 - 161
  • [22] A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma
    Rudnick, Jeremy D.
    Sarmiento, J. Manuel
    Uy, Benjamin
    Nuno, Miriam
    Wheeler, Christopher J.
    Mazer, Mia J.
    Wang, Hongqiang
    Hu, Jethro L.
    Chu, Ray M.
    Phuphanich, Surasak
    Black, Keith L.
    Yu, John S.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 74 : 187 - 193
  • [23] Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model
    Grauer, Oliver M.
    Sutmuller, Roger P. M.
    van Maren, Wendy
    Jacobs, Joannes F. M.
    Bennink, Erik
    Toonen, Liza W. J.
    Nierkens, Stefan
    Adema, Gosse J.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (08) : 1794 - 1802
  • [24] Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma
    Jiang, Xiao-bing
    Lu, Xiao-ling
    Hu, Peng
    Liu, Ru-en
    VACCINE, 2009, 27 (44) : 6210 - 6216
  • [25] Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma
    Kim, Jung Han
    Lee, Yoon
    Bae, Yong-Soo
    Kim, Won Seog
    Kim, Kihyun
    Im, Ho Yeong
    Kang, Won Ki
    Park, Keunchil
    Choi, Han Yong
    Lee, Hyun Moo
    Kang, Won Ki
    Lee, Hyunah
    Doh, Hyounmie
    Kim, Byong-Moon
    Kim, Chae Young
    Jeon, ChoonJu
    Jung, Chu Won
    CLINICAL IMMUNOLOGY, 2007, 125 (03) : 257 - 267
  • [26] Induction of cellular immune response against autologous tumor cells by vaccination with autologous tumor lysate-pulsed dendritic cells
    Yasumoto, Kosei
    So, Tetsuya
    Nose, Naohiro
    Yoshimatsu, Takashi
    Tomiyama, Mai
    Maekawa, Ryuji
    LUNG CANCER, 2012, 77 : S27 - S27
  • [27] CLINICAL STUDY PHASE II WITH DENDRITIC CELL VACCINATION AND TUMOUR LYSATE AS ADD-ON THERAPY IN HIGH GRADE GLIOMA
    Stragliotto, G.
    Holm, S.
    Adamson, L.
    Giraud, G.
    Hansson, M.
    Henter, J.
    NEURO-ONCOLOGY, 2012, 14 : 25 - 25
  • [28] CLINICAL STUDY PHASE II WITH DENDRITIC CELL VACCINATION AND TUMOUR LYSATE AS ADD-ON THERAPY IN HIGH GRADE GLIOMA
    Stragliotto, G.
    Holm, S.
    Adamson, L.
    Giraud, G.
    Henter, J. I.
    NEURO-ONCOLOGY, 2014, 16
  • [29] Treatment with tumor lysate-pulsed autologous dendritic cells prolongs survival in patients with recurrent glioblastoma multiforme
    Bosch, Marnix
    Prins, Robert
    Liau, Linda
    CANCER RESEARCH, 2015, 75
  • [30] A phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma
    Rudnick, J. D.
    Phuphanich, S.
    Chu, R.
    Mazer, M.
    Wang, H.
    Serrano, N.
    Francisco, M.
    Black, K. L.
    Wheeler, C.
    Yu, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345